Logo

Health Canada Approves Seegene's Multiplex Respiratory Virus Tests

Dec 03, 2008
NEW YORK (GenomeWeb News) – Seegene said today that Health Canada has approved two of its multiplex diagnostic tests for respiratory infections.
 
Health Canada awarded Medical Device Licenses for the company’s PCR-based Seeplex RV5 Auto Capillary Electrophoresis Screening and RV12 Auto Capillary Electrophoresis Detection tests.
 
The Seeplex RV5 test detects influenza A, influenza B, and respiratory syncytial virus A/B, and screens for 11 viruses; while the RV12 test identifies 12 viruses individually.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.